» Articles » PMID: 28632339

Polymorphisms of Human Leukocyte Antigen B*27 on Clinical Phenotype of Spondyloarthritis in Chinese

Overview
Journal J Clin Lab Anal
Publisher Wiley
Date 2017 Jun 21
PMID 28632339
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Background: In recent years, an ever-increasing number of alleles of human leukocyte antigen B*27 (HLA-B*27) have been identified. This study aimed to establish an updated method for HLA-B*27 subtyping, and to investigate the impact of HLA-B*27 polymorphisms on the clinical phenotype of spondyloarthritis (SpA).

Methods: Overall, 184 SpA patients were recruited for analyzing diversity of HLA-B*27 via an updated high-resolution polymerase chain reaction amplification with sequence specific primers (PCR-SSP).

Results: The prevalence of HLA-B*27 was 94.0%, and four subtypes were identified including HLA-B*2704 (77.5%), B*2705 (20.2%), B*2707 (1.7%), and B*2724 (0.6%). There was an obvious male predominance (P=.05) and markedly elevated C-reaction protein (CRP) in B*27 positive SpA (P<.01). In multivariate linear regression analysis, the elevated CRP was positively associated with HLA-B*27 positivity (regression coefficient B=46.1, P=.0003), grade of sacroiliitis (B=47.5, P=.0032), and male gender (B=20.4, P=.0041). Notably, a male predilection was also found in B*2705 positive SpA while B*2707 was associated with older age, higher positive family history, and higher prevalence of extra-articular features (all P<.05).

Conclusions: In this study, an updated PCR-SSP technique to identify increasing alleles of HLA-B*27 was developed and their different effects on clinical manifestations of SpA were demonstrated. Genotyping of HLA-B*27 would shed light on our understanding of the pathogenesis of SpA.

Citing Articles

Sarcopenia and Variation in the Human Leukocyte Antigen Complex.

Jones G, Pilling L, Kuo C, Kuchel G, Ferrucci L, Melzer D J Gerontol A Biol Sci Med Sci. 2019; 75(2):301-308.

PMID: 30772894 PMC: 7176057. DOI: 10.1093/gerona/glz042.


Polymorphisms of human leukocyte antigen B*27 on clinical phenotype of spondyloarthritis in Chinese.

Ma H, Yin Q, Liu Y, Wu Y, Zhu T, Guo M J Clin Lab Anal. 2017; 32(2).

PMID: 28632339 PMC: 6816982. DOI: 10.1002/jcla.22275.

References
1.
Evans D, Spencer C, Pointon J, Su Z, Harvey D, Kochan G . Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility. Nat Genet. 2011; 43(8):761-7. PMC: 3640413. DOI: 10.1038/ng.873. View

2.
Marcilla M, de Castro J . Peptides: the cornerstone of HLA-B27 biology and pathogenetic role in spondyloarthritis. Tissue Antigens. 2008; 71(6):495-506. DOI: 10.1111/j.1399-0039.2008.01051.x. View

3.
van Tubergen A, Weber U . Diagnosis and classification in spondyloarthritis: identifying a chameleon. Nat Rev Rheumatol. 2012; 8(5):253-61. DOI: 10.1038/nrrheum.2012.33. View

4.
Cauli A, Dessole G, Fiorillo M, Vacca A, Mameli A, Bitti P . Increased level of HLA-B27 expression in ankylosing spondylitis patients compared with healthy HLA-B27-positive subjects: a possible further susceptibility factor for the development of disease. Rheumatology (Oxford). 2002; 41(12):1375-9. DOI: 10.1093/rheumatology/41.12.1375. View

5.
BREWERTON D, Hart F, Nicholls A, Caffrey M, James D, Sturrock R . Ankylosing spondylitis and HL-A 27. Lancet. 1973; 1(7809):904-7. DOI: 10.1016/s0140-6736(73)91360-3. View